Sage Journals: Discover world-class research

Abstract

Objectives

Major and minor amputations are associated with significant rates of mortality. However, little is known about the impact of unplanned redo-amputation during the same hospitalization on outcomes. The objectives of this study were to identify the risk factors associated with in-hospital mortality after both major and minor amputations as well as the results of unplanned redo-amputation on outcome.

Methods

Retrospective study of 342 consecutive patients who were treated with lower extremity amputation in Brazil between January 2013 and October 2014.

Results

The in-hospital mortality rate was higher in major compared to minor amputation (25.6% vs. 4.1%; p < 0.0001). Whereas chronic kidney disease, chronic obstructive pulmonary disease, and planned staged amputation predicted in-hospital mortality after major amputation, age, and congestive heart failure predicted mortality after minor amputation. The white blood cell count predicted in-hospital mortality following both major and minor amputation. However, postoperative infection predicted in-hospital mortality only following major amputation.

Conclusions

In-hospital mortality was high after major amputations. Unplanned redo-amputation was not a predictor of in-hospital mortality after major or minor amputation. Planned staged amputation was associated with reduced survival after major but not minor amputation. Postoperative infection predicted mortality after major amputation. Systemic diseases and postoperative white blood cell were associated with in-hospital mortality. This study suggests a possible link between a pro-inflammatory state and increased in-hospital mortality following amputation.

Keywords

Amputation redo-amputation infection in-hospital mortality unplanned redo-amputation

Get full access to this article

View all access options for this article.

References

Sharath

Henson

Flynn

et al . Ambulation and independence among Veterans with nontraumatic bilateral lower-limb loss. J Rehabil Res Dev 2015; 52: 851–858.

Dormandy

Heeck

and Vig

Major amputations: clinical patterns and predictors. Semin Vasc Surg 1999; 12: 154–161.

Ziegler-Graham

MacKenzie

Ephraim

et al . Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 2008; 89: 422–429.

Aulivola

Hile

Hamdan

et al . Major lower extremity amputation: outcome of a modern series. Arch Surg 2004; 139: 395–399; discussion 9.

Basu

Fassiadis

and McIrvine

Mobility one year after unilateral lower limb amputation: a modern, UK institutional report. Interact Cardiovasc Thorac Surg 2008; 7: 1024–1026.

Feinglass

Pearce

Martin

et al . Postoperative and late survival outcomes after major amputation: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. Surgery 2001; 130: 21–29.

Lim

Finlayson

Thorpe

et al . Outcomes of a contemporary amputation series. ANZ J Surg 2006; 76: 300–305.

Nelson

Greenblatt

Soma

et al . Preoperative factors predict mortality after major lower-extremity amputation. Surgery 2012; 152: 685–694; discussion 94–96.

Fortington

Geertzen

van Netten

et al . Short and long term mortality rates after a lower limb amputation. Eur J Vasc Endovasc Surg 2013; 46: 124–131.

10.

Assi

Al Azzi

Protack

et al . Chronic kidney disease predicts long-term mortality after major lower extremity amputation. North Am J Med Sci 2014; 6: 321–327.

11.

Karam

Shepard

and Rubinfeld

Predictors of operative mortality following major lower extremity amputations using the National Surgical Quality Improvement Program public use data. J Vasc Surg 2013; 58: 1276–1282.

12.

Subramaniam

Pomposelli

Talmor

et al . Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics. Anesth Analg 2005; 100: 1241–1247.

13.

Lavery

van Houtum

Armstrong

et al . Mortality following lower extremity amputation in minorities with diabetes mellitus. Diabetes Res Clin Pract 1997; 37: 41–47.

14.

Lamm

Auer

Weber

et al . Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 2006; 20: 51–56.

15.

White

Kelly

and Dunsmuir

C-reactive protein level after total hip and total knee replacement. J Bone Joint Surg Br 1998; 80: 909–911.

16.

Armenian

et al . Cardiovascular disease among survivors of adult-onset cancer: A community-based retrospective cohort study. JCO 2016; 34: 1122–1130.

17.

Yang

Cho

et al . Clinical outcomes after rescue extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest. Emerg Med J 2017; 34: 107–111.

18.

Tokunaga

Ogawa

Ito

et al . Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension. J Cardiol 2016; 68: 542–547.

19.

Hambleton

Jonnalagadda

Davis

et al . All-cause mortality after diabetes-related amputation in Barbados: a prospective case-control study. Diabetes Care 2009; 32: 306–307.

20.

Kristensen

Holm

Kirketerp-Moller

et al . Very low survival rates after non-traumatic lower limb amputation in a consecutive series: what to do? Interact Cardiovasc Thorac Surg 2012; 14: 543–547.

21.

Ghaferi

Birkmeyer

and Dimick

JB.

Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009; 361: 1368–1375.

22.

Lavery

van Houtum

and Harkless

LB.

In-hospital mortality and disposition of diabetic amputees in The Netherlands. Diabet Med 1996; 13: 192–197.

23.

Mayfield

Reiber

Maynard

et al . Survival following lower-limb amputation in a veteran population. J Rehabil Res Dev 2001; 38: 341–345.

24.

Kazmers

Perkins

and Jacobs

LA.

Major lower extremity amputation in Veterans Affairs medical centers. Ann Vasc Surg 2000; 14: 216–222.

25.

Brown

Giles

and Croft

JB.

White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001; 54: 316–322.

26.

Weijenberg

Feskens

and Kromhout

White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996; 16: 499–503.

27.

Gillum

Ingram

and Makuc

DM.

White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1993; 125: 855–863.

28.

de Labry

Campion

Glynn

et al . White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol 1990; 43: 153–157.

29.

Grimm

Jr. Neaton

and Ludwig

Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985; 254: 1932–1937.

30.

Ross

The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809.

31.

Ernst

Hammerschmidt

Bagge

et al . Leukocytes and the risk of ischemic diseases. JAMA 1987; 257: 2318–2324.

32.

Fuster

and Lewis

Conner memorial lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2126–2146.

33.

Shankar

Wang

Rochtchina

et al . Association between circulating white blood cell count and cancer mortality: a population-based cohort study. Arch Intern Med 2006; 166: 188–194.

34.

Yeung

and Buncio

AD.

Leukocyte count, smoking, and lung function. Am J Med 1984; 76: 31–37.

35.

Thomsen

Ingebrigtsen

Marott

et al . Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013; 309: 2353–2361.

36.

Moberg

Vestbo

Martinez

et al . Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease. Scient World J 2014; 2014: 140736.

37.

Turin

Tonelli

Manns

et al . Chronic kidney disease and life expectancy. Nephrol Dial Transpl 2012; 27: 3182–3186.

38.

Dossa

Shepard

Amos

et al . Results of lower extremity amputations in patients with end-stage renal disease. J Vasc Surg 1994; 20: 14–19.

39.

Mendoza-Sassi

Béria

and Barros

AJD.

Outpatient health service utilization and associated factors: a population-based study. Rev Saúde Pública 2003; 37: 372–378.

General outcomes and risk factors for minor and major amputations in Brazil